J Clin Oncol. 2021; CRS Management Guideline
18 Questions
4 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the first symptom of Cytokine Release Syndrome (CRS)?

  • Neurologic symptoms
  • Hypoxia
  • Fever (correct)
  • Hypertension
  • Which biomarker is used as a surrogate for IL-6 activity in CRS?

  • Hemoglobin
  • Ferritin
  • C-reactive protein (CRP) (correct)
  • Creatinine
  • What is a common approach to managing CRS?

  • Administering high doses of acetaminophen
  • Administering antihistamines only
  • Use of corticosteroids as a first-line treatment (correct)
  • Intubation for any reason not related to hypoxia
  • In CRS, what organ system may also be affected in addition to fever and hypotension?

    <p>Cardiovascular system</p> Signup and view all the answers

    What is a characteristic feature of Immune effector-associated neurotoxicity syndrome (ICANS) in CRS?

    <p>It is classified as a separate entity from CRS</p> Signup and view all the answers

    What intervention is recommended for early management of CRS?

    <p>Early intervention with tocilizumab</p> Signup and view all the answers

    What is the recommended additional medication due to the use of steroids in CRS management?

    <p>Bactrim</p> Signup and view all the answers

    In the case study, what was the initial treatment for the grade 1 CRS?

    <p>Fluid bolus</p> Signup and view all the answers

    What role did the APP play in managing CRS in the case study?

    <p>Ordered a chest x-ray</p> Signup and view all the answers

    What was the result of the chest x-ray in the case study?

    <p>Pleural effusions</p> Signup and view all the answers

    What was the ANC level that prompted the start of empiric IV antibiotics in the case study?

    <p>&lt; 1.0</p> Signup and view all the answers

    What additional symptom prompted consultation with the infectious disease team in the case study?

    <p>Fever</p> Signup and view all the answers

    What is the most severe grade of Cytokine Release Syndrome (CRS) according to the CTCAE v5.0 grading system?

    <p>Grade 4</p> Signup and view all the answers

    According to ASCO Guidelines, how is Grade 2 CRS managed?

    <p>Administer tocilizumab and repeat every 8 hours if no improvement</p> Signup and view all the answers

    What symptom is associated with Grade 3 CRS according to ASCO Guidelines?

    <p>Hypoxia requiring &gt; 40% FIO2</p> Signup and view all the answers

    Which medication may be considered if hypotension persists after tocilizumab and fluid boluses in Grade 2 CRS?

    <p>Dexamethasone</p> Signup and view all the answers

    What additional action is recommended for management in Grade 3 CRS according to ASCO Guidelines?

    <p>Obtain an echocardiogram if not yet done</p> Signup and view all the answers

    In the context of CRS management, when should Grade 4 CRS be managed as refractory?

    <p>If hypotension persists after tocilizumab and one pressor</p> Signup and view all the answers

    Study Notes

    Cytokine Release Syndrome (CRS) Overview

    • The first symptom of CRS is often fever.
    • A key biomarker used as a surrogate for IL-6 activity in CRS is serum C-reactive protein (CRP).

    Management of CRS

    • Common approaches to managing CRS include monitoring and supportive care.
    • Organ systems affected in CRS can include the neurological system, in addition to fever and hypotension.
    • Immune effector-associated neurotoxicity syndrome (ICANS) is characterized by encephalopathy and neurological impairments.

    Early Management Interventions

    • Early intervention in CRS management often includes the administration of tocilizumab.
    • Due to steroid use in CRS management, additional medications like short-acting insulin may be recommended to manage hyperglycemia.

    Case Study Insights

    • Initial treatment for grade 1 CRS included observation and supportive care.
    • The Advanced Practice Provider (APP) played a crucial role in coordinating care and monitoring symptoms in the case study.
    • A chest x-ray performed in the case study resulted in findings that were consistent with CRS-related effects, although specific details are not provided.
    • An absolute neutrophil count (ANC) level of less than 500 prompted the initiation of empiric IV antibiotics in the case study.
    • An additional symptom that led to consultation with the infectious disease team was a significant drop in blood pressure.

    CRS Grading and Management Guidelines

    • The most severe grade of CRS is Grade 4 according to the CTCAE v5.0 grading system.
    • Management of Grade 2 CRS involves the use of tocilizumab along with close monitoring.
    • Grade 3 CRS is marked by symptoms such as high fever, hypotension, or severe fatigue.
    • If hypotension persists in Grade 2 CRS after the administration of tocilizumab and fluid boluses, vasopressors may be considered.
    • For Grade 3 CRS, additional actions include potential escalation of care and consideration for ICU admission.
    • Grade 4 CRS should be managed as refractory if it does not respond to initial treatments and support measures.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on the 21 ASCO Guideline for managing Cytokine Release Syndrome (CRS) in the context of CAR T-cell therapy. Learn about considerations such as early steroid use, monitoring CD4 counts, adding Bactrim and antifungal prophylaxis.

    More Like This

    CAR T-cell Therapy Process
    10 questions

    CAR T-cell Therapy Process

    WellManneredCarbon avatar
    WellManneredCarbon
    CAR T-Cell Therapy in B-ALL Patients
    37 questions
    CAR T-Cell Therapy in Childhood Cancer
    5 questions
    Use Quizgecko on...
    Browser
    Browser